These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16381230)

  • 41. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
    Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
    Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
    Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
    Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epidemiology of viral hepatitis].
    Kaić B; Vilibić-Cavlek T; Filipović SK; Nemeth-Blazić T; Pem-Novosel I; Vucina VV; Simunović A; Zajec M; Radić I; Pavlić J; Glamocanin M; Gjenero-Margan I
    Acta Med Croatica; 2013 Oct; 67(4):273-9. PubMed ID: 24984326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
    Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
    Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epidemiology and transmission of hepatitic C].
    Stauber R
    Wien Med Wochenschr; 2000; 150(23-24):460-2. PubMed ID: 11205174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for viral hepatitis among male non-drug-abuse prisoners.
    Liao KF; Lai SW; Chang WL; Hsu NY
    Scand J Gastroenterol; 2006 Aug; 41(8):969-73. PubMed ID: 16803696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiology of HCV infection in Poland and the world].
    Braczkowska B; Kowalska M
    Wiad Lek; 2002; 55 Suppl 1():61-8. PubMed ID: 15002220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of spread of hepatitis C.
    Alter MJ
    Hepatology; 2002 Nov; 36(5 Suppl 1):S93-8. PubMed ID: 12407581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and risk factors for hepatitis C virus infection among adolescents in detention.
    Bair RM; Baillargeon JG; Kelly PJ; Lerand SJ; Williams JF; Lyerla R; Alter MJ
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1015-8. PubMed ID: 16275789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Epidemiology of hepatitis C virus in Peru and Latin America].
    Dávalos Moscol M
    Rev Gastroenterol Peru; 2009; 29(4):347-54. PubMed ID: 20066020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of hepatitis C in Croatia in the European context.
    Vilibic-Cavlek T; Kucinar J; Kaic B; Vilibic M; Pandak N; Barbic L; Stevanovic V; Vranes J
    World J Gastroenterol; 2015 Aug; 21(32):9476-93. PubMed ID: 26327756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hepatitis C: risk factors].
    Vargas Vorácková F
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S9-10. PubMed ID: 12712843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and economic importance of hepatitis B in the Federal Republic of Germany.
    Lange W; Masihi KN
    Postgrad Med J; 1987; 63 Suppl 2(741):21-6. PubMed ID: 3684845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.